# US 2006/0153885 A1 · Dry eye treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153885 A1
- Document ID: US20060153885A1
- Status: Published application
- Kind: A1
- Application number: 11/034,527
- Filed: 2005-01-12
- Published: 2006-07-13
- Earliest claimed: 2005-01-12
- Assignees: Ocular Research of Boston, Inc.
- Inventors: Donald Korb; Chris Brancewicz
- Web page: https://patentgrep.com/patent/US20060153885A1

## CPC

- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61P 27/02: Ophthalmic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention relates to an emulsion composition for the formation of an artificial tear film over the ocular surface of the eye capable of providing mechanical lubrication for the ocular surface while reducing evaporation of fluid therefrom. The emulsion is desirably in the form of a meta stable emulsion and is characterized by the use of a surfactant comprising a combination of a primary and secondary surfactant where the primary surfactant permits formation of the emulsion and the secondary surfactant permits autoclaving of the surfactant. The invention also includes a method for the formation of such an emulsion.

## Claims

### Claim 1

An oil in water emulsion, said emulsion using as emulsifiers a combination of a primary surfactant and a secondary surfactant, said primary surfactant being a physiologically acceptable surfactant capable of forming a stable emulsion at physiological pH by itself or in combination with a secondary surfactant, and a secondary surfactant, differing from the primary surfactant and used in combination with the primary surfactant, said secondary surfactant being a physiologically acceptable surfactant capable of maintaining the emulsion stable during autoclaving at temperatures in excess of 75° C. or higher.

### Claim 2 (depends on 1)

The emulsion of claim 1 where the emulsion is stable during manufacture and storage, but meta stable when applied to the ocular surface whereby it differentiates into a separate water and oil phase rapidly following insertion into the eye.

### Claim 3 (depends on 2)

The emulsion of claim 2 where the phases differentiate within 1 minute of addition to the eye.

### Claim 4 (depends on 3)

The emulsion of claim 3 where differentiation takes place within the shorter time of 30 seconds or the time required for five blinks of the eye.

### Claim 5 (depends on 1)

The emulsion of claim 1 where the concentration of the surfactant combination used to form the emulsion is at least 0.01 weight percent of the total composition.

### Claim 6 (depends on 5)

The emulsion of claim 5 where the concentration of the surfactant combination varies between 0.05 to 3.0 percent of the total composition.

### Claim 7 (depends on 5)

The emulsion of claim 5 where the concentration of the surfactant combination varies between 0.25 and 2.5 percent by weight of the total composition.

### Claim 8 (depends on 1)

The emulsion of claim 1 where the concentration of the oil is at least 1.0 percent of the weight of the total composition.

### Claim 9 (depends on 8)

The emulsion of claim 8 where the concentration of the oil varies between about 2.5 and 12.5 percent by weight of the composition.

### Claim 10 (depends on 9)

The emulsion of claim 9 where the concentration of oil is that amount required to add between 1 and 10 ul of oil to the eye.

### Claim 11 (depends on 1)

The emulsion of claim 1 where the primary surfactant, the secondary surfactant, or both is a mixture of surfactants.

### Claim 12 (depends on 1)

The emulsion of claim 1 where the secondary surfactant has ethylene oxide hydrophilic groups.

### Claim 13 (depends on 1)

The emulsion of claim 1 where the secondary surfactant is a member selected from the group consisting of C8H17C6H4(OCH2CH2)OHn where n is between 5 and 70 and C9H19C6H4(OCH2CH2)OHp where p is between 5 and 40, and a polyoxyethylene C12-22 alkyl ether.

### Claim 14 (depends on 13)

The emulsion of claim 13 where n varies between 30 and 50 and p varies between 15 and 30.

### Claim 15

An oil in water emulsion, said emulsion using as emulsifiers a combination of a primary surfactant and a secondary surfactant, said primary surfactant being a physiologically acceptable surfactant capable of forming a stable emulsion at physiological pH by itself or in combination with a secondary surfactant, and a secondary surfactant, differing from the primary surfactant and used in combination with the primary surfactant, said secondary surfactant being a physiologically acceptable polyethoxylate capable of maintaining the emulsion stable during autoclaving at temperatures in excess of 75° C. or higher.

### Claim 16 (depends on 15)

The emulsion of claim 15 where the secondary surfactant has at least 9 repeating ethoxylate groups.

### Claim 17 (depends on 15)

The emulsion of claim 15 where the emulsion is stable during manufacture and storage, but meta stable when applied to the ocular surface whereby it differentiates into a separate water and oil phase rapidly following insertion into the eye.

### Claim 18 (depends on 17)

The emulsion of claim 17 where the phases differentiate within I minute of addition to the eye.

### Claim 19 (depends on 18)

The emulsion of claim 18 where differentiation takes place within the shorter time of 30 seconds or the time required for five blinks of the eye.

### Claim 20 (depends on 15)

The emulsion of claim 15 where the secondary surfactant is an Octoxynol.

### Claim 21 (depends on 15)

The emulsion of claim 15 where the primary surfactant is a polyoxyethylene ether.

### Claim 22 (depends on 21)

The emulsion of claim 21 where the primary surfactant is a polyoxyethylenie sorbitan stearate.

### Claim 23 (depends on 15)

The emulsion of claim 15 where the concentration of the surfactant combination used to form the emulsion is at least 0.01 weight percent of the total composition.

### Claim 24 (depends on 23)

The emulsion of claim 23 where the concentration of the surfactant combination varies between 0.25 and 2.5 percent by weight of the total composition.

### Claim 25 (depends on 15)

The emulsion of claim 15 where the concentration of the oil is at least 1.0 percent of the weight of the total composition.

### Claim 26 (depends on 25)

The emulsion of claim 25 where the concentration of the oil varies between about 2.5 and 12.5 percent by weight of the composition.

### Claim 27 (depends on 25)

The emulsion of claim 25 where the concentration of oil is that amount required to add between 1 and 10 ul of oil to the eye.

### Claim 28 (depends on 15)

The emulsion of claim 15 where the primary surfactant, the secondary surfactant, or both is a mixture of surfactants.

### Claim 29

A method for the formation of a meta stable oil in water emulsion able to withstand temperatures in excess of 75° C. without formation of a separate oil layer, the emulsion having an oil concentration of from 2.5 and 12.5 percent by weight and a maximum surfactant concentration of 2.5 percent by weight, said method comprising the steps of [1] selecting a first surfactant that (a) is approved for use on the ocular surface of the human eye, (b) enables formation of an emulsion having the above component concentration levels at physiological pH and is stable during storage, or capable of being reconstituted by simple shaking; and (c) enables formation of an emulsion which, when applied to the ocular surface, differentiates within a minute or less; [2] selecting a second surfactant that (a) is approved for use on the ocular surface of the eye, (b) is compatible with the remaining components of the emulsion; and (b) enables autoclaving at temperatures required to sterilize the emulsion but does not prevent breaking of the emulsion when applied to the ocular surface; and [3] mixing the components of the emulsion to form the emulsion.

### Claim 30 (depends on 29)

The method of claim 29 formulated to differentiate following addition to the eye within the shorter time of 30 seconds or the time required for five blinks of the eye.

### Claim 31 (depends on 29)

The method of claim 29 where the concentration of the surfactant combination used to form the emulsion varies between 0.25 and 2.5 percent by weight of the total composition.

### Claim 32 (depends on 29)

The method of claim 29 where the concentration of oil is that amount required to add between 1 and 10 ul of oil to the eye.

### Claim 33 (depends on 29)

The method of claim 29 where the secondary surfactant is a polyethoxylate.

### Claim 34 (depends on 29)

The method of claim 29 where the secondary surfactant is a member selected from the group consisting of C8H17C6H4(OCH2CH2)OHn where n is between 5 and 70 and C9H19C6H4(OCH2CH2)OHp where p is between 5 and 40, and a polyoxyethylene C12-22 alkyl ether.

### Claim 35 (depends on 34)

The method of claim 34 where n varies between 30 and 50 and p varies between 15 and 30.
